Tag Archives: #ASCO17

Getting Personal at ASCO 2017: Precision Therapies, IO, and Autologous Cell Therapy
June 13, 2017

This blog was written by Michael Gladstone, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC. The 2017 American Society of Clinical Oncology (“ASCO”) meeting concluded last week, providing patients, physicians, and industry stakeholders with

1 Comment